OpenAlex
PricingAboutJobs
Log inGet started
Work

Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study

HTML

Year: 2015
Type: article
Source: Leukemia
DOI: 10.1038/leu.2015.14
Authors: V Goede, K Fischer, A Engelke, R Schlag, S Lepretre, L F C Montero, M Montillo, C Fegan, E Asikanius, K Humphrey, G Fingerle-Rowson, M Hallek
Institutions: University of Cologne, Deutsche CLL Studiengruppe (DCLLSG), Centre Henri Becquerel, Hospital Virgen de la Salud, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, University Hospital of Wales, F. Hoffmann-La Roche AG, Roche (United Kingdom), Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
Language: English

Topic: Chronic Lymphocytic Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: obinutuzumab, chronic lymphocytic leukemia, first-line therapy, fludarabine, cyclophosphamide, treatment-naive patients, B-cell receptor inhibitor, venetoclax, cost-effectiveness
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W2066357502
FWCI: 30.67
Cites: 14
Cited by: 263
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms